Promising Targets and Strategies to Control Neuroinflammation (Part I)
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Current medicinal chemistry - 29(2022), 27 vom: 25., Seite 4630 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Federico, Stephanie [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 18.08.2022 Date Revised 18.08.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/092986732927220629150904 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344933326 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344933326 | ||
003 | DE-627 | ||
005 | 20231226023917.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/092986732927220629150904 |2 doi | |
028 | 5 | 2 | |a pubmed24n1149.xml |
035 | |a (DE-627)NLM344933326 | ||
035 | |a (NLM)35974678 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Federico, Stephanie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Promising Targets and Strategies to Control Neuroinflammation (Part I) |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.08.2022 | ||
500 | |a Date Revised 18.08.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 7 | |a Receptors, GABA |2 NLM | |
700 | 1 | |a Moro, Stefano |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g 29(2022), 27 vom: 25., Seite 4630 |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2022 |g number:27 |g day:25 |g pages:4630 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/092986732927220629150904 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2022 |e 27 |b 25 |h 4630 |